Organization | The Gerber Foundation

The Gerber Foundation Report issue

Foundation Phase 1 Phase 2 Phase 3 Phase 4

Founded: Fremont MI United States (1952)

Organization Overview

First Clinical Trial

2004

NCT00678925

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2022

Timeline

NOW

Now

Alternative names

The Gerber Foundation

Active Ingredients

Drugs in Phase 4 Trials (2)

caffeine (2 trials)

rocuronium (zemuron) (1 trial)

Drugs in Phase 3 Trials (3)

bifidobacterium animalis (1 trial)

glucose monohydrate (1 trial)

levocarnitine (carnitor) (1 trial)

Drugs in Phase 2 Trials (2)

fish oil (Omegavan) (1 trial)

medium chain triglyceride (1 trial)

Drugs in Phase 1 Trials (2)

lactoferrin (2 trials)

vitamin a (1 trial)

Drugs in Other Trials (9)

dexmedetomidine (precedex) (1 trial)

famotidine (pepcid) (1 trial)

fentanyl (Innovar) (1 trial)

human milk (3 trials)

isoflurane (forane) (1 trial)

lactobacillus reuteri (1 trial)

phosphatidylcholine (1 trial)

vitamin d3 (1 trial)

water (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Birth Weight (Phase 1)

Body Weight (Phase 1)

Bronchopulmonary Dysplasia (Phase 4)

Neurodevelopmental Disorders (Phase 3)

Premature Birth (Phase 3)

Respiratory Distress Syndrome (Phase 4)

Respiratory Distress Syndrome, Newborn (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 17
# of Trial APIs: 18